These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8539943)

  • 1. Survival of islet grafts in perforin-deficient mice.
    Lu X; Ledermann B; Borel JF
    Transplant Proc; 1995 Dec; 27(6):3262-3. PubMed ID: 8539943
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance induction to islet allografts following infusion of perforin deficient bone marrow.
    Selvaggi G; Inverardi L; Levy RB; Mintz DH; Podack ER; Ricordi C
    Transplant Proc; 1995 Dec; 27(6):3193. PubMed ID: 8539907
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
    Beilke JN; Kuhl NR; Van Kaer L; Gill RG
    Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for granzyme B, in addition to perforin and TNFalpha, in alloreactive CTL-induced mouse pancreatic beta cell death.
    Sutton VR; Estella E; Li C; Chen M; Thomas HE; Kay TW; Trapani JA
    Transplantation; 2006 Jan; 81(2):146-54. PubMed ID: 16436955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rapamycin on islet xenograft survival.
    Lu X; Schuurman HJ; Borel JF
    Transplant Proc; 1994 Jun; 26(3):1128-9. PubMed ID: 8029857
    [No Abstract]   [Full Text] [Related]  

  • 7. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet rejection in perforin-deficient mice: the role of perforin and Fas.
    Ahmed KR; Guo TB; Gaal KK
    Transplantation; 1997 Apr; 63(7):951-7. PubMed ID: 9112346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
    Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
    Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice.
    Sambhara S; Switzer I; Kurichh A; Miranda R; Urbanczyk L; James O; Underdown B; Klein M; Burt D
    Cell Immunol; 1998 Jul; 187(1):13-8. PubMed ID: 9681998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.
    Mandel T; Dillon H; Koulmanda M
    Transplant Proc; 1995 Dec; 27(6):3569. PubMed ID: 8540105
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of rejection of nonvascularized grafts: the role of perforin and Fas.
    Selvaggi G; Ricordi C; Podack E; Inverardi L
    Transplant Proc; 1997 Jun; 29(4):2075-6. PubMed ID: 9193534
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
    Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
    J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice.
    Baker MB; Podack ER; Levy RB
    Biol Blood Marrow Transplant; 1995 Dec; 1(2):69-73. PubMed ID: 9118294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoisolative effectiveness and limitation of agarose in a bioartificial pancreas.
    Iwata H; Takagi T; Kobayashi K; Yang H; Ito F
    Transplant Proc; 1994 Apr; 26(2):789. PubMed ID: 8171663
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.